The groundbreaking approach of this peptide represents a significant advance in the management of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – providing improved blood sugar management and potential weight reduction. Scientists are studying its potential … Read More